Physician profile
Anna E Marjan
NPI 1346621919
$3,364.79
in general payments reported to CMS, 2019-2025
13 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $107 · 2021: $641 · 2022: $381 · 2023: $610 · 2024: $608 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,469.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $836.82 | 2021-2024 | In.Pact Admiral |
| W. L. Gore & Associates, INC. | $762.07 | 2019-2025 | Gore Tag Thoracic Endoprosthesis, Viabahn Endoprosthesis With Propaten Bioactive Surface, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Penumbra, INC. | $687.21 | 2021-2025 | Indigo System |
| Medtronic Vascular, INC. | $344.98 | 2019 | |
| Abbott Laboratories | $229.97 | 2024 | Esprit |
| Bolton Medical INC | $159.87 | 2019 | |
| Cook Medical LLC | $103.06 | 2019 | |
| Boston Scientific Corporation | $79.75 | 2021-2022 | |
| Philips North America LLC | $69.23 | 2022 | |
| Cordis US Corp. | $26.13 | 2023 | Brite Tip Radianz |
| Sirtex Medical INC | $25.61 | 2024 | Sir-Spheres Microspheres |
| Medtronic USA, INC. | $24.39 | 2019 | |
| Bard Peripheral Vascular, INC. | $15.70 | 2023 | Crosser Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Marjan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.